SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-077374
Filing Date
2014-02-28
Accepted
2014-02-28 16:18:00
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K d649879d10k.htm 10-K 913468
2 CONSENT d649879dex231.htm EX-23.1 2417
3 CERTIFICATION d649879dex311.htm EX-31.1 8107
4 CERTIFICATION d649879dex312.htm EX-31.2 8123
5 CERTIFICATION d649879dex321.htm EX-32.1 4035
6 CERTIFICATION d649879dex322.htm EX-32.2 4017
  Complete submission text file 0001193125-14-077374.txt   6117049

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ogen-20131231.xml EX-101.INS 619414
8 XBRL TAXONOMY EXTENSION SCHEMA ogen-20131231.xsd EX-101.SCH 70223
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ogen-20131231_cal.xml EX-101.CAL 70941
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ogen-20131231_def.xml EX-101.DEF 242909
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogen-20131231_lab.xml EX-101.LAB 528720
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogen-20131231_pre.xml EX-101.PRE 359651
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32188 | Film No.: 14655606
SIC: 2834 Pharmaceutical Preparations